Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 8/2013

01-10-2013 | Original Paper

Charges for Criminal Exposure to HIV and Aggravated Prostitution Filed in the Nashville, Tennessee Prosecutorial Region 2000–2010

Authors: Carol L. Galletly, Zita Lazzarini

Published in: AIDS and Behavior | Issue 8/2013

Login to get access

Abstract

This paper examines comprehensive data on arrests for HIV-specific crimes within a single jurisdiction, the Nashville Tennessee prosecutorial region, over 11 years. There were 25 arrests for HIV exposure and 27 for aggravated prostitution. Eleven of the arrests for HIV exposure involved nonsexual behaviors; none alleged transmission. Sixteen of the arrests for HIV exposure involved sexual behavior; three alleged transmission. Aggravated prostitution cases (i.e. prostitution while knowing one has HIV) often involved solicitation of oral sex; none alleged transmission. Maximum sentences for HIV-specific crimes ranged from 5 to 8 years. We conclude that enforcement of US HIV-specific laws is underestimated. Fifty-two arrests over 11 years were recorded in one jurisdiction. Over half of the arrests involved behaviors posing minimal or no HIV transmission risk. Despite concerns about malicious, intentional HIV transmission, no cases alleged malice or intention.
Literature
1.
Criminal exposure of another to HIV (human immunodeficiency virus), hepatitis B virus (HBV), or to hepatitis C virus (HCV). 2012; Tenn. Code Ann. §39-13-109.
2.
Aggravated prostitution. 2012; Tenn. Code Ann. §39-13-516.
3.
Lazzarini Z, Bray S, Burris S. Evaluating the impact of criminal laws on HIV risk behavior. J Law Med Ethics. 2002;30(2):239–55.PubMedCrossRef
4.
5.
Authorized terms of imprisonment and fines for felonies and misdemeanors. 2012; Tenn. Code Ann. §40-35-111.
6.
Prostitution. 2012; Tenn. Code Ann. §39-13-513.
7.
Tennessee sexual offender and violent sexual offender registration. verification, and tracking act of 2004. 2012; Tenn. Code Ann. §40-39-201-215.
8.
National Alliance of State & Territorial AIDS Directors. Understanding State Departments of Health and Corrections Collaboration: a summary of survey findings –Part II and strategic guidance towards ending criminalization-related stigma and discrimination; 2011. www.​nastad.​org/​HIVC/​decriminalizatio​n_​findings.​pdf. Accessed 24 Oct 12.
9.
10.
Burris S, Cameron E. The case against criminalization of HIV transmission. JAMA. 2008;300(5):578–81.PubMedCrossRef
11.
Galletly CL, Pinkerton SD. Conflicting messages: how criminal HIV disclosure laws undermine public health efforts to control the spread of HIV. AIDS Behav. 2006;10(5):451–61.PubMedCrossRef
12.
Vittinghoff E, Douglas J, Judson F, McKirnan D, MacQueen K, Buchbinder SP. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol. 1999;150(3):306–11.PubMedCrossRef
13.
Baggaley RF, White RG, Boily M. Systematic review of orogenital HIV-1 transmission probabilities. Int J Epidemiol. 2008;37:1255–65.PubMedCrossRef
14.
Friedman H. To protect and serve? Trial. 2011;47:14–7.
15.
Dodds C, Bourne A, Weait M. Responses to criminal prosecutions for HIV transmission among gay men with HIV in England and Wales. Reprod Health Matters. 2009;17(34):135–45.PubMedCrossRef
16.
Dodds C, Keogh P. Criminal prosecutions for HIV transmission: people living with HIV respond. Int J STD AIDS. 2006;17:315–8.PubMedCrossRef
17.
Galletly CL, Dickson-Gomez JB. HIV sero-positive status disclosure to prospective sex partners and criminal laws that require it: perspectives of persons living with HIV. Int J STD AIDS. 2009;20(9):613–8.PubMedCrossRef
18.
Galletly CL, DiFranceisco W, Pinkerton SD. HIV-positive persons’ awareness and understanding of their states’ criminal HIV disclosure law. AIDS Behav. 2009;13:1262–9.PubMedCrossRef
19.
Horvath KJ, Weinmeyer R, Rosser S. Should it be illegal for HIV-positive persons to have unprotected sex without disclosure? An examination of attitudes among US men who have sex with men and the impact of state law. AIDS Care. 2010;22:1221–8.PubMedCrossRef
20.
21.
Klitzman R, Kirshenbaum S, Kittel L, et al. Naming names: perceptions of name-based reporting, partner notification, and the criminalization of nondisclosure among persons living with HIV. Sex Res Soc Policy. 2004;1(3):38–57.CrossRef
22.
Galletly CL, Pinkerton SD, DiFrancesico W. A quantitative study of Michigan’s criminal HIV exposure law. AIDS Care. 2011;24(2):174–9.PubMed
23.
Burris S, Beletsky L, Burleson J, Case P, Lazzarini Z. Do criminal laws influence HIV risk behavior? An empirical trial. Arizona State Law J. 2007;39:467–519.
24.
O’Byrne P, Bryan A, Woodyatt C. Nondisclosure prosecutions and HIV prevention: results from an Ottawa-based gay men’s sex survey. J Assoc Nurses in AIDS Care. 2012;[ahead of publication].
25.
Adam BD, Elliott R, Husbands W, Murray J, Maxwell J. Effects of the criminalization of HIV transmission in Cuerrier on men reporting unprotected sex with men. Can J Law and Soc. 2008;23:143–59.
26.
Galletly CL, Glasman LR, Pinkerton SD, DiFranceisco W. New Jersey’s HIV exposure law and the HIV-related attitudes, beliefs, and sexual and seropositive status disclosure behaviors of persons living with HIV. Am J Public Health. 2012;102(11):2135–40.PubMedCrossRef
27.
Mykhalovskiy E. The problem of “significant risk”: exploring the public health impact of criminalizing HIV non-disclosure. Soc Sci Med. 2011;73:668–75.PubMedCrossRef
28.
Hoppe T. Punishing HIV: how michigan trial courts frame felony HIV disclosure cases. Presentation at International AIDS Conference 2012, Washington, DC; 25 Jun 2012.
Metadata
Title
Charges for Criminal Exposure to HIV and Aggravated Prostitution Filed in the Nashville, Tennessee Prosecutorial Region 2000–2010
Authors
Carol L. Galletly
Zita Lazzarini
Publication date
01-10-2013
Publisher
Springer US
Published in
AIDS and Behavior / Issue 8/2013
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-013-0408-1

Other articles of this Issue 8/2013

AIDS and Behavior 8/2013 Go to the issue

Original Paper

The Effect of Exposures to Policing on Syringe Sharing Among People Who Inject Drugs in Bangkok, Thailand

Original Paper

Multilevel Stigma as a Barrier to HIV Testing in Central Asia: A Context Quantified

Original Paper

A Preliminary RCT of CBT-AD for Adherence and Depression Among HIV-Positive Latinos on the U.S.-Mexico Border: The Nuevo Día Study

Original Paper

Law Enforcement Practices Associated with HIV Infection Among Injection Drug Users in Odessa, Ukraine

Original Paper

Context Matters: The Moderating Role of Bar Context in the Association Between Substance Use During Sex and Condom Use Among Male Clients of Female Sex Workers in Tijuana, Mexico

Original Paper

Adherence to HIV Treatment and Care Among Previously Homeless Jail Detainees
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits